Mainz, June 20, 2018 – Computational Analysis becomes ever more important for the advancement of personalized medicine. Bioinformatics accelerate the patient-centric molecular characterization of diseases and lead to a deeper understanding of the underlying mechanisms thus facilitating the development of novel drugs. Progress in Artificial Intelligence has a strong impact on clinical decision making in diagnosis and treatment. Nowadays, collection of huge amounts of data in the clinic and the lab is straight forward. However, the challenge lies within the analysis to draw the right conclusion from this big data.
Dr. Martin Löwer will give an impulse talk in session ‘Data analysis for disease characterization and diagnostics’
For further information prease visit the organizer’s website.